25328

    533573

    APLLTD

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ALEMBIC PHARMA LTD Share Price Today

    ALEMBIC PHARMA LTD is currently trading at ₹809.4, up by ₹3.65 from the previous close. The stock touched an intraday high of ₹825.00 and a low of ₹799.10 during the latest trading session. Over the past one year, ALEMBIC PHARMA LTD has delivered a loss of 16.69%, while the stock has declined 2.17% in the last one month.

    ALEMBIC PHARMA LTD performance

    Today’s low Today’s high
    ₹ 799.10 ₹ 825.00
    ₹ 809.40
    52 week low 52 week high
    ₹ 635.80 ₹ 1002.00
    ₹ 809.40
    Open Price ₹ 805.75
    Prev. Close ₹ 805.75
    Volume (Shares) 485095.00
    Total traded value ₹ 3926.35
    Upper Circuit ₹ 966.90
    Lower Circuit ₹ 644.60
    info

    Investment Returns

    Over 1 Month -2.17% Over 3 Months 5.22% Over 6 Months 1.78% Over 1 Year -16.69%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ALEMBIC PHARMA LTD fundamentals


    • Market cap (Cr) 15,909.80
    • P/E Ratio (TTM) 24.74
    • Beta 0.93
    • Book Value / share 285.67
    • Return on equity 12.90%
    • EPS (TTM) 35.46
    • Dividend yield 1.49%
    • Net profit/quarter (Cr) 243.07
    info icon alternate text
    • Market cap (Cr) 15,913.80
    • P/E Ratio (TTM) 24.74
    • Beta 0.88
    • Book Value / share 285.67
    • Return on equity 12.90%
    • EPS (TTM) 35.46
    • Dividend yield 1.49%
    • Net profit/quarter (Cr) 243.07
    info icon alternate text

    ALEMBIC PHARMA LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 1718.74
    Operating Expense 1546.40
    Net Profit 243.07
    Net Profit Margin (%) 14.14
    Earnings Per Share (EPS) 12.37
    EBITDA 275.19
    Effective Tax Rate (%) -40.13
    Particulars DEC 2025 (Values in Cr)
    Revenue 1642.24
    Operating Expense 1471.96
    Net Profit 114.47
    Net Profit Margin (%) 6.97
    Earnings Per Share (EPS) 5.82
    EBITDA 240.10
    Effective Tax Rate (%) 17.51
    Particulars SEP 2025 (Values in Cr)
    Revenue 1796.24
    Operating Expense 1591.37
    Net Profit 179.36
    Net Profit Margin (%) 9.98
    Earnings Per Share (EPS) 9.12
    EBITDA 314.80
    Effective Tax Rate (%) 17.09
    Particulars JUN 2025 (Values in Cr)
    Revenue 1494.17
    Operating Expense 1376.44
    Net Profit 103.52
    Net Profit Margin (%) 6.92
    Earnings Per Share (EPS) 5.27
    EBITDA 221.53
    Effective Tax Rate (%) 17.52
    Particulars MAR 2025 (Values in Cr)
    Revenue 1570.64
    Operating Expense 1492.29
    Net Profit 75.34
    Net Profit Margin (%) 4.79
    Earnings Per Share (EPS) 3.83
    EBITDA 183.87
    Effective Tax Rate (%) 17.71
    Particulars MAR 2026 (Values in Cr)
    Revenue 6651.38
    Operating Expense 5986.18
    Net Profit 640.42
    Net Profit Margin (%) 9.62
    Earnings Per Share (EPS) 32.58
    EBITDA 1051.62
    Effective Tax Rate (%) 2.09
    Particulars MAR 2025 (Values in Cr)
    Revenue 6032.63
    Operating Expense 5484.79
    Net Profit 503.12
    Net Profit Margin (%) 8.33
    Earnings Per Share (EPS) 25.60
    EBITDA 962.14
    Effective Tax Rate (%) 17.33
    Particulars MAR 2024 (Values in Cr)
    Revenue 5874.06
    Operating Expense 5201.15
    Net Profit 666.48
    Net Profit Margin (%) 11.34
    Earnings Per Share (EPS) 33.91
    EBITDA 1029.84
    Effective Tax Rate (%) 5.36
    Particulars MAR 2023 (Values in Cr)
    Revenue 5149.00
    Operating Expense 4806.62
    Net Profit 346.73
    Net Profit Margin (%) 6.73
    Earnings Per Share (EPS) 17.64
    EBITDA 667.88
    Effective Tax Rate (%) -0.23
    Particulars MAR 2022 (Values in Cr)
    Revenue 5035.41
    Operating Expense 4428.54
    Net Profit 543.55
    Net Profit Margin (%) 10.79
    Earnings Per Share (EPS) 27.65
    EBITDA 959.95
    Effective Tax Rate (%) 17.39
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 288.72
    ROE % 12.35
    ROCE % 11.24
    Total Debt to Total Equity 0.25
    EBITDA Margin 15.06
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 264.10
    ROE % 11.63
    ROCE % 13.08
    Total Debt to Total Equity 0.18
    EBITDA Margin 15.95
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 245.14
    ROE % 13.40
    ROCE % 12.93
    Total Debt to Total Equity 0.13
    EBITDA Margin 15.42
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 222.36
    ROE % 7.12
    ROCE % 7.20
    Total Debt to Total Equity 0.15
    EBITDA Margin 12.03
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 266.47
    ROE % 10.11
    ROCE % 10.91
    Total Debt to Total Equity 0.13
    EBITDA Margin 17.53
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 285.69
    ROE % 12.90
    ROCE % 12.01
    Total Debt to Total Equity 0.22
    EBITDA Margin 16.84
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 264.30
    ROE % 9.96
    ROCE % 11.40
    Total Debt to Total Equity 0.17
    EBITDA Margin 15.95
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 249.75
    ROE % 14.30
    ROCE % 14.13
    Total Debt to Total Equity 0.13
    EBITDA Margin 17.53
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 224.59
    ROE % 7.15
    ROCE % 6.98
    Total Debt to Total Equity 0.15
    EBITDA Margin 12.97
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 269.16
    ROE % 10.46
    ROCE % 11.38
    Total Debt to Total Equity 0.12
    EBITDA Margin 19.06
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 202.70
    Total Assets 8762.58
    Total Liabilities 8762.58
    Total Equity 5668.98
    Share Outstanding 19
    Price to Book Ratio 2.32
    Return on Assets (%) 7.70
    Return on Capital (%) 9.6
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 90.10
    Total Assets 7772.95
    Total Liabilities 7772.95
    Total Equity 5189.52
    Share Outstanding 19
    Price to Book Ratio 3.52
    Return on Assets (%) 7.50
    Return on Capital (%) 9.14
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 126.57
    Total Assets 6445.58
    Total Liabilities 6445.58
    Total Equity 4818.20
    Share Outstanding 19
    Price to Book Ratio 3.93
    Return on Assets (%) 9.55
    Return on Capital (%) 11.73
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 82.27
    Total Assets 6182.83
    Total Liabilities 6182.83
    Total Equity 4370.47
    Share Outstanding 19
    Price to Book Ratio 2.21
    Return on Assets (%) 5.53
    Return on Capital (%) 6.83
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 69.43
    Total Assets 7122.03
    Total Liabilities 7122.03
    Total Equity 5237.54
    Share Outstanding 19
    Price to Book Ratio 2.75
    Return on Assets (%) 7.31
    Return on Capital (%) 8.88
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 28.74
    Total Assets 8151.24
    Total Liabilities 8151.24
    Total Equity 5615.26
    Share Outstanding 19
    Price to Book Ratio 2.32
    Return on Assets (%) 7.85
    Return on Capital (%) 9.47
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 20.85
    Total Assets 7556.26
    Total Liabilities 7556.26
    Total Equity 5194.74
    Share Outstanding 19
    Price to Book Ratio 3.52
    Return on Assets (%) 6.65
    Return on Capital (%) 7.94
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 26.49
    Total Assets 6398.55
    Total Liabilities 6398.55
    Total Equity 4908.91
    Share Outstanding 19
    Price to Book Ratio 3.93
    Return on Assets (%) 10.41
    Return on Capital (%) 12.51
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 28.46
    Total Assets 6130.42
    Total Liabilities 6130.42
    Total Equity 4414.29
    Share Outstanding 19
    Price to Book Ratio 2.21
    Return on Assets (%) 5.65
    Return on Capital (%) 6.87
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 21.90
    Total Assets 7074.04
    Total Liabilities 7074.04
    Total Equity 5290.34
    Share Outstanding 19
    Price to Book Ratio 2.75
    Return on Assets (%) 7.68
    Return on Capital (%) 9.18
    Particulars MAR 2026 (Values in Cr)
    Net Income 693.95
    Cash from Operations 886.44
    Cash from Investing -506.06
    Cash from Financing -163.78
    Net change in Cash 112.89
    Free Cash Flow 1321.06
    Particulars MAR 2025 (Values in Cr)
    Net Income 707.18
    Cash from Operations 159.35
    Cash from Investing -568.41
    Cash from Financing 443.72
    Net change in Cash -36.73
    Free Cash Flow 722.97
    Particulars MAR 2024 (Values in Cr)
    Net Income 631.83
    Cash from Operations 823.05
    Cash from Investing -320.61
    Cash from Financing -437.86
    Net change in Cash 44.73
    Free Cash Flow 1150.52
    Particulars MAR 2023 (Values in Cr)
    Net Income 354.59
    Cash from Operations 784.64
    Cash from Investing -447.60
    Cash from Financing -261.96
    Net change in Cash 14.39
    Free Cash Flow 1228.05
    Particulars MAR 2022 (Values in Cr)
    Net Income 625.39
    Cash from Operations 675.78
    Cash from Investing -371.97
    Cash from Financing -217.35
    Net change in Cash -36.97
    Free Cash Flow 1101.42
    Particulars MAR 2026 (Values in Cr)
    Net Income 654.11
    Cash from Operations 889.01
    Cash from Investing -483.43
    Cash from Financing -317.60
    Net change in Cash 8.44
    Free Cash Flow 1320.98
    Particulars MAR 2025 (Values in Cr)
    Net Income 608.59
    Cash from Operations 272.23
    Cash from Investing -636.07
    Cash from Financing 403.61
    Net change in Cash -5.90
    Free Cash Flow 835.24
    Particulars MAR 2024 (Values in Cr)
    Net Income 704.23
    Cash from Operations 782.80
    Cash from Investing -329.02
    Cash from Financing -445.29
    Net change in Cash -1.54
    Free Cash Flow 1107.32
    Particulars MAR 2023 (Values in Cr)
    Net Income 345.93
    Cash from Operations 784.03
    Cash from Investing -460.98
    Cash from Financing -261.16
    Net change in Cash 8.11
    Free Cash Flow 1227.29
    Particulars MAR 2022 (Values in Cr)
    Net Income 658.01
    Cash from Operations 674.06
    Cash from Investing -368.72
    Cash from Financing -216.64
    Net change in Cash -40.10
    Free Cash Flow 1096.42
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 37.26 15.46 1.80 285.54 23.12 38.85
    BLISS GVS PHARMA LTD 465.70 37.50 4.14 4947.78 118.35 552.90
    CIPLA LTD 1469.00 33.16 3.44 118672.48 1165.55 1672.20
    FERMENTA BIOTECH LTD. 511.60 23.93 3.70 1505.69 256.40 518.45
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 37.26 26.06 4.80 285.54 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 520.40 23.33 4.06 1504.51 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8296.00 108.42 23.76 20740.00 7630.00 9850.00
    BLISS GVS PHARMA LTD 465.70 50.40 4.28 4947.78 118.35 552.90

    ALEMBIC PHARMA LTD shareholding pattern

    Holding
    10.0%
    69.87%
    4.17%
    15.93%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    ALEMBIC PHARMA LTD Technicals Summary

    809.40 0.45 redarrow
    red-green-graph indicator
    7 Bearish
    9 Bullish
    • 5 Days 805.70
    • 26 Days 807.70
    • 10 Days 809.90
    • 50 Days 794.30
    • 12 Days 810.90
    • 100 Days 785.80
    • 20 Days 810.50
    • 200 Days 810.90
    798.72 PIVOT
    First Support 791.58 First Resistance 804.18 Second Support 786.12 Second Resistance 811.32 Third Support 778.98 Third Resistance 816.78
    RSI 49.48 ADX 14.92 MACD 3.17 Williams % R -73.01 Commodity Channel Index (CCI) -88.90
    Date 2026-08-03 Week 29845.00 Same Day 26955.00 Month 44073.00
    1 Year 0.93 3 Year 0.71
    Over 1 Month
    -2.17% down
    Over 1 Year
    -16.69% down
    Over 3 Months
    5.22% down
    Over 3 Years
    1.04% down
    Over 6 Months
    1.78% down
    Over 5 Years
    0.49% down

    ALEMBIC PHARMA LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    29 Jul 2026 12.0 Final 29 Jul 2026 Equity shares
    29 Jul 2025 11.0 Final 29 Jul 2025 Equity shares
    15 Jul 2024 11.0 Final 15 Jul 2024 Equity shares
    28 Jul 2023 8.0 Final 28 Jul 2023 Equity shares
    17 Aug 2022 10.0 Interim 18 Aug 2022 Equity shares
    19 Jul 2021 14.0 Final 21 Jul 2021 Equity shares
    16 Mar 2020 7.0 Interim 17 Mar 2020 Equity shares
    16 Mar 2020 3.0 Special 17 Mar 2020 Equity shares
    18 Jul 2019 5.5 Final 22 Jul 2019 Equity shares
    18 Jul 2018 4.0 Final 20 Jul 2018 Equity shares
    11 Jul 2017 4.0 Final 13 Jul 2017 Equity shares
    20 Jul 2016 4.0 Final 22 Jul 2016 Equity shares
    22 Jul 2015 3.5 Final 24 Jul 2015 Equity shares
    17 Jul 2014 3.0 Final 21 Jul 2014 Equity shares
    29 Jul 2013 2.5 Final 31 Jul 2013 Equity shares
    31 Jul 2012 1.4 Final 02 Aug 2012 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    29 Jul 2026 12.0 Final 29 Jul 2026 Equity shares
    29 Jul 2025 11.0 Final 29 Jul 2025 Equity shares
    15 Jul 2024 11.0 Final 15 Jul 2024 Equity shares
    28 Jul 2023 8.0 Final 28 Jul 2023 Equity shares
    17 Aug 2022 10.0 Interim 18 Aug 2022 Equity shares
    19 Jul 2021 14.0 Final 21 Jul 2021 Equity shares
    16 Mar 2020 7.0 Interim 17 Mar 2020 Equity shares
    16 Mar 2020 3.0 Special 17 Mar 2020 Equity shares
    18 Jul 2019 5.5 Final 22 Jul 2019 Equity shares
    18 Jul 2018 4.0 Final 20 Jul 2018 Equity shares
    11 Jul 2017 4.0 Final 13 Jul 2017 Equity shares
    20 Jul 2016 4.0 Final 22 Jul 2016 Equity shares
    22 Jul 2015 3.5 Final 24 Jul 2015 Equity shares
    17 Jul 2014 3.0 Final 21 Jul 2014 Equity shares
    29 Jul 2013 2.5 Final 31 Jul 2013 Equity shares
    31 Jul 2012 1.4 Final 02 Aug 2012 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Alembic Pharmaceuticals Ltd?

    Answer Field

    Alembic Pharmaceuticals Ltd share price is for NSE ₹ 809.40 & for BSE ₹ 812.50 as on Aug 04 2026 03:30 PM.

    What is the Market Cap of Alembic Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Alembic Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 04 2026 03:30 PM.

    What is the 52 Week High and Low of Alembic Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Alembic Pharmaceuticals Ltd for NSE is ₹ 1,002.00 and ₹ 635.80 and for BSE is ₹ 1,004.95 and ₹ 635.30.

    What is 1 year return for Alembic Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been -16.69%.

    What is the P/E Ratio of Alembic Pharmaceuticals Ltd Share?

    Answer Field

    As on Aug 04 2026 03:30 PM the price-to-earnings (PE) ratio for Alembic Pharmaceuticals Ltd share is 24.74.

    What is the PB ratio of Alembic Pharmaceuticals Ltd Share?

    Answer Field

    As on Aug 04 2026 03:30 PM, the price-to-book (PB) ratio for Alembic Pharmaceuticals Ltd share is 285.67.

    How to Buy Alembic Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Alembic Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Alembic Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Alembic Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Alembic Pharmaceuticals Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |